[1] Emmett SD, Francis HW. The socioeconomic impact of hearing loss in U.S. adults[J]. Otol Neurotol, 2015,36(3): 545-550.
[2] Cox RM, Johnson JA, Xu J. Impact of advanced hearing aid technology on speech understanding for older listeners with mild to moderate, adult-onset, sensorineural hearing loss[J]. Gerontology, 2014,60(6): 557-568.
[3] Gupta S, Eavey RD, Wang M, et al. Type 2 diabetes and the risk of incident hearing loss[J]. Diabetologia, 2019,62(2): 281-285.
[4] Meyer zum Gottesberge AM, Massing T, Sasse A, et al. Zucker diabetic fatty rats, a model for type 2 diabetes, develop an inner ear dysfunction that can be attenuated by losartan treatment[J]. Cell Tissue Res, 2015, 362(2): 307-315.
[5] Kim MB, Zhang YY, Chang YS, et al. Diabetes mellitus and the incidence of hearing loss: a cohort study[J]. Int J Epidemiol, 2017, 46(2): 717-726.
[6] Zhang P, Lin X, Qu Y. Connexin and deafness[J]. Chinese Journal of Otology, 2013,11(1): 156-159.(in Chinese)
张璞, 林曦, 曲雁.Connexin蛋白与耳聋[J]. 中华耳科学杂志, 2013,11(1): 156-159.
[7] Ly A, Yee P, Vessey KA, et al.Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss[J]. Invest Ophthalmol Vis Sci, 2011, 52(13): 9316-9326.
[8] Gao H, Wen JJ, Hu JL, et al, Fermented Momordica charantia L. juice modulates hyperglycemia, lipid profile, and gut microbiota in type 2 diabetic rats [J]. Food Res Int, 2019, 121(7): 367-378.
[9] Li W, Chang M, Qiu M, Chen Y, et al, Exogenous obestatin decreases beta-cell apoptosis and alfa-cell proliferation in high fat diet and streptozotocin induced type 2 diabetic rats [J]. Eur J Pharmacol, 2019,851:36-42.
[10] Li Y, Fan PY,Ma XY, et al. A long-term and stable method for the preparation of a type 2 diabetes Sprague-Dawley rat model[J]. Acta Laboratorium Animalis Scientia Sinica, 2020, 28(3): 364-369.(in Chinese)
黎娅,范培云,马晓雨,等. 长期稳定的 SD 大鼠 2 型糖尿病模型制备方法[J]. 中国实验动物学报,2020,28(3): 364-369.
[11] Vaughan N, James K, McDermott D, et al. Auditory brainstem response differences in diabetic and non-diabetic veterans[J]. J Am Acad Audiol, 2007, 18(10): 863-871.
[12] Wang ShL, Chen XM, Bi DZh, et al. Ultrastructural changes of inner ear capillaries in experimental diabetic rats [J]. Journal of Audiology and Speech Pathology, 2006, 14(4):278-279.
王士礼,陈学明,毕道周,等.实验性糖尿病大鼠内耳毛细血管超微结构变化[J]. 听力学与言语疾病杂志, 2006, 14(4): 278-279
[13] Huang GW, Li GQ, Yan XJ, et al. Characteristics of hearing loss in diabetic fat rats[J]. Chinese Journal of Otology, 2016, 14(6): 813-818.(in Chinese)
黄国威, 李国庆, 严晓菊, 等.糖尿病性耳聋听力变化特点[J]. 中华耳科学杂志, 2016, 14(6): 813-818.
[14] Lee HS, Kim KR, Chung WH, et al. Early sensorineural hearing loss in ob/ob mouse, an animal model of type 2 diabetes[J]. Clin Exp Otorhinolaryngol, 2008, 1(4): 211-216.
[15] Cohen-Salmon M, Ott T, Michel Ⅴ, et al. Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death[J]. Curr Biol, 2002, 12(13): 1106-1111.
[16] Kudo T, Kure S, Ikeda K, et al. Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness[J]. Hum Mol Genet, 2003, 12(9): 995-1004.
[17] Teubner B, Michel V,Pesch, J, et al. Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential[J]. Hum Mol Genet, 2003, 12(1):13-21.
|